|
1
|
Sakaguchi S, Miyara M, Costantino CM and
Hafler DA: FOXP3+ regulatory T cells in the human immune system.
Nat Rev Immunol. 10:490–500. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mauri C and Menon M: Human regulatory B
cells in health and disease: Therapeutic potential. J Clin Invest.
127:772–779. 2017. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Flores-Borja F, Bosma A, Ng D, Reddy V,
Ehrenstein MR, Isenberg DA and Mauri C: CD19+CD24hiCD38hi B cells
maintain regulatory T cells while limiting TH1 and TH17
differentiation. Sci Transl Med. 5:173ra232013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Oleinika K, Rosser EC, Matei DE, Nistala
K, Bosma A, Drozdov I and Mauri C: CD1d-dependent immune
suppression mediated by regulatory B cells through modulations of
iNKT cells. Nat Commun. 9:6842018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Vomhof-DeKrey EE, Yates J, Hägglöf T,
Lanthier P, Amiel E, Veerapen N, Besra GS, Karlsson MC and
Leadbetter EA: Cognate interaction with iNKT cells expands
IL-10-producing B regulatory cells. Proc Natl Acad Sci USA.
112:12474–12479. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Olkhanud PB, Damdinsuren B, Bodogai M,
Gress RE, Sen R, Wejksza K, Malchinkhuu E, Wersto RP and Biragyn A:
Tumor-evoked regulatory B cells promote breast cancer metastasis by
converting resting CD4+ T cells to T-regulatory cells.
Cancer Res. 71:3505–3515. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bodogai M, Lee Chang C, Wejksza K, Lai J,
Merino M, Wersto RP, Gress RE, Chan AC, Hesdorffer C and Biragyn A:
Anti-CD20 antibody promotes cancer escape via enrichment of
tumor-evoked regulatory B cells expressing low levels of CD20 and
CD137L. Cancer Res. 73:2127–2138. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Horikawa M, Minard-Colin V, Matsushita T
and Tedder TF: Regulatory B cell production of IL-10 inhibits
lymphoma depletion during CD20 immunotherapy in mice. J Clin
Invest. 121:4268–4280. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Swerdlow SH, Campo E, Pileri SA, Harris
NL, Stein H, Siebert R, Advani R, Ghielmini M, Salles GA, et al:
The 2016 revision of the World Health Organization classification
of lymphoid neoplasms. Blood. 127:2375–2390. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Boulassel MR, Al-Ghonimi M, Al-Balushi B,
Al-Naamani A, Al-Qarni Z, Wali Y, Elshinawy M, Al-Shezawi M, Khan
H, Nazir H, et al: Regulatory B Cells Are Functionally Impaired in
Patients Having Hemophilia A With Inhibitors. Clin Appl Thromb
Hemost. 24:618–624. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Boulassel MR, Mercier F, Gilmore N and
Routy JP: Immunophenotypic patterns of CD8+ T cell subsets
expressing CD8α and IL-7Rα in viremic, aviremic and slow progressor
HIV-1-infected subjects. Clin Immunol. 124:149–157. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gunduz E, Sermet S and Musmul A:
Peripheral blood regulatory T cell levels are correlated with some
poor prognostic markers in newly diagnosed lymphoma patients.
Cytometry B Clin Cytom. 90:449–454. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lin H, Sun XF, Zhen ZJ, Xia Y, Ling JY,
Huang HQ, Xia ZJ and Lin TY: Correlation between peripheral blood
CD4+CD25high CD127low regulatory T cell and clinical
characteristics of patients with non-Hodgkin's lymphoma. Chin J
Cancer. 28:1186–1192. 2009. View Article : Google Scholar
|
|
14
|
Han Y, Wu J, Bi L, Xiong S, Gao S, Yin L,
Jiang L, Chen C, Yu K and Zhang S: Malignant B cells induce the
conversion of CD4+CD25- T cells to regulatory T cells in
B-cell non-Hodgkin lymphoma. PLoS One. 6:e286492011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mittal S, Marshall NA, Duncan L, Culligan
DJ, Barker RN and Vickers MA: Local and systemic induction of
CD4+CD25+ regulatory T-cell population by non-Hodgkin lymphoma.
Blood. 111:5359–5370. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cao J, Guo P, Xiao S and Fu X:
Relationship of regulatory T cell level in peripheral blood with
curative efficacy and prognosis of patients with non-Hodgkin's
lymphoma. Int J Clin Exp Pathol. 9:11876–11882. 2016.
|
|
17
|
Chang C, Wu SY, Kang YW, Lin KP, Chen TY,
Medeiros LJ and Chang KC: High levels of regulatory T cells in
blood are a poor prognostic factor in patients with diffuse large
B-cell lymphoma. Am J Clin Pathol. 144:935–944. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mohr A, Malhotra R, Mayer G, Gorochov G
and Miyara M: Human FOXP3+ T regulatory cell heterogeneity. Clin
Transl Immunology. 7:e10052018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang J and Ke XY: The four types of Tregs
in malignant lymphomas. J Hematol Oncol. 4:502011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Qiu H, Li J, Feng Z, Yuan J, Lu J, Hu X,
Gao L, Lv S, Yang J and Chen L: CD19(+) CD20(−) CD27(hi)
IL-s10-producing B cells are overrepresented in R-CHOP-treated
DLBCL patients in complete remission. Clin Exp Pharmacol Physiol.
43:795–801. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Pierini A, Nishikii H, Baker J, Kimura T,
Kwon HS, Pan Y, Chen Y, Alvarez M, Strober W, Velardi A, et al:
Foxp3+ regulatory T cells maintain the bone marrow microenvironment
for B cell lymphopoiesis. Nat Commun. 8:150682017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhao E, Xu H, Wang L, Kryczek I, Wu K, Hu
Y, Wang G and Zou W: Bone marrow and the control of immunity. Cell
Mol Immunol. 9:11–19. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Metelitsa LS: Anti-tumor potential of
type-I NKT cells against CD1d-positive and CD1d-negative tumors in
humans. Clin Immunol. 140:119–129. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yoneda K, Morii T, Nieda M, Tsukaguchi N,
Amano I, Tanaka H, Yagi H, Narita N and Kimura H: The peripheral
blood Vα24+ NKT cell numbers decrease in patients with
haematopoietic malignancy. Leuk Res. 29:147–152. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hus I, Bojarska-Junak A, Kamińska M,
Dobrzyńska-Rutkowska A, Szatan K, Szymczyk A, Kukiełka-Budny B,
Szczepanek D and Roliński J: Imbalance in circulatory iNKT, Th17
and T regulatory cell frequencies in patients with B-cell
non-Hodgkin's lymphoma. Oncol Lett. 14:7957–7964. 2017.PubMed/NCBI
|
|
26
|
Yan-Li L, Kang-Sheng G, Yue-Yin P, Yang J
and Zhi-Min Z: The lower peripheral blood lymphocyte/monocyte ratio
assessed during routine follow-up after standard first-line
chemotherapy is a risk factor for predicting relapse in patients
with diffuse large B-cell lymphoma. Leuk Res. 38:323–328. 2014.
View Article : Google Scholar : PubMed/NCBI
|
